Guardant Health Appoints New CEO, Adds Directors
Ticker: GH · Form: 8-K · Filed: May 31, 2024 · CIK: 1576280
| Field | Detail |
|---|---|
| Company | Guardant Health, Inc. (GH) |
| Form Type | 8-K |
| Filed Date | May 31, 2024 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.00001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: leadership-change, board-of-directors, ceo-appointment
Related Tickers: GH
TL;DR
New CEO Amirali Talasaz takes over Guardant Health, board gets shake-up.
AI Summary
Guardant Health, Inc. announced on May 24, 2024, a change in its board of directors. Specifically, Dr. Amirali Talasaz has been appointed as the new Chief Executive Officer, succeeding Helmy Eltoukhy. The company also announced the election of two new directors, Ms. Sarah Cannon and Mr. David E. R. Gross, to its Board of Directors.
Why It Matters
This filing indicates a significant leadership transition at Guardant Health, with a new CEO and board members, which could signal a shift in strategic direction or operational focus for the company.
Risk Assessment
Risk Level: medium — Leadership changes and board restructuring can introduce uncertainty regarding future strategy and execution, impacting investor confidence.
Key Players & Entities
- Guardant Health, Inc. (company) — Registrant
- Dr. Amirali Talasaz (person) — Appointed Chief Executive Officer
- Helmy Eltoukhy (person) — Departing Chief Executive Officer
- Ms. Sarah Cannon (person) — Elected Director
- Mr. David E. R. Gross (person) — Elected Director
- May 24, 2024 (date) — Date of earliest event reported
FAQ
Who has been appointed as the new CEO of Guardant Health?
Dr. Amirali Talasaz has been appointed as the new Chief Executive Officer.
Who did Dr. Amirali Talasaz succeed as CEO?
Dr. Amirali Talasaz succeeded Helmy Eltoukhy as CEO.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on May 24, 2024.
How many new directors were elected to the Board of Directors?
Two new directors, Ms. Sarah Cannon and Mr. David E. R. Gross, were elected to the Board of Directors.
What is the principal executive office address for Guardant Health, Inc.?
The principal executive office address is 3100 Hanover Street, Palo Alto, California 94304.
Filing Stats: 1,140 words · 5 min read · ~4 pages · Grade level 17.2 · Accepted 2024-05-31 16:25:31
Key Financial Figures
- $0.00001 — ange on which registered Common Stock, $0.00001 par value per share GH The Nasdaq G
Filing Documents
- d809302d8k.htm (8-K) — 31KB
- 0001193125-24-151836.txt ( ) — 148KB
- gh-20240524.xsd (EX-101.SCH) — 3KB
- gh-20240524_lab.xml (EX-101.LAB) — 17KB
- gh-20240524_pre.xml (EX-101.PRE) — 11KB
- d809302d8k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. GUARDANT HEALTH, INC. Date: May 31, 2024 By: /s/ John G. Saia John G. Saia Chief Legal Officer and Corporate Secretary